Published in Gene Therapy Weekly, August 10th, 2000
"One major objective of tumor immunologists is to prevent cancer development in individuals at high risk," wrote C.T. Siegel and colleagues, University of Chicago, Illinois. "(TG.ACxC57BL/6)F1 mice serve as a model for testing the feasibility of this objective."
Siegel et al. published their study in the Journal of Experimental Medicine ("Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein," J Exp Med, 2000;191(11):1945-1956).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly